930
MUTATIONS IN XANTHENE DEHYDROGENASE (XDH) ASSOCIATED WITH INHERITED SUSCEPTIBILITY TO BARRETT'S NEOPLASIA
Date
May 9, 2023
Explore related products in the following collection:
Tracks
Related Products
INTRODUCTION
SOCIETY: AGA
AGA Improving Outcomes in Barrett's Esophagus and Esophageal Adenocarcinoma
Barrett's esophagus is the only precancerous condition for esophageal adenocarcinoma; a cancer that is associated with rising incidence and high morbidity and mortality rates…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…